QLC7401 in Participants With Heterozygous Familial Hypercholesterolemia (HeFH)

NCT07450378 · clinicaltrials.gov ↗

PHASE3

Phase

NOT_YET_RECRUITING

Status

120

Enrollment

INDUSTRY

Sponsor class

Conditions

Heterozygous Familial Hypercholesterolemia (HeFH)

Interventions

DRUG: QLC7401 Injection
DRUG: Placebo

Sponsor

Qilu Pharmaceutical Co., Ltd.